It is NOT possible to use chemical substances as medicine, medicine, active substance, medical aid, cosmetic product, substance for the production of a cosme​tic product...

Peptides
Ipamorelin 5mg + CJC-1295 5mg
Research compound

Ipamorelin 5mg + CJC-1295 5mg

Price
85,00 CHF

Ipamorelin 10 mg research-grade lyophilized peptide powder in a glass vial. Ipamorelin is a selective growth hormone secretagogue and ghrelin/GHS-R agonist studied in models of growth hormone secretion, endocrine signaling and ghrelin-pathway research.

CJC-1295 NO DAC 5 mg research-grade lyophilized peptide powder supplied in a glass vial. CJC-1295 NO DAC, also known as Modified GRF (1-29) or Mod GRF 1-29, is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH) studied in experimental models of pituitary growth hormone release, GHRH receptor agonism and pulsatile GH secretion.

✓Third party tested
✓High purity and quality
✓Research use only
Research use only: this product is intended exclusively for laboratory, analytical or collector purposes. It is not intended for human or veterinary use, food use, dietary supplementation, cosmetic use or as a medicine.

Ipamorelin 10mg

Ipamorelin 10 mg research-grade lyophilized peptide powder in a glass vial. Ipamorelin is a selective growth hormone secretagogue and ghrelin/GHS-R agonist studied in models of growth hormone secretion, endocrine signaling and ghrelin-pathway research.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
99%+ (HPLC, third-party tested)
Form
Lyophilized peptide powder
Content
10 mg Ipamorelin per vial
Appearance
White to off-white powder
Packaging
Glass vial with sterile closure
Storage
2–8 °C (lyophilized), protect from light, keep desiccated
Molecular Formula
C38H49N9O5
Molecular Weight
~711.9 g·mol⁻¹
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide)
CAS Number
170851-70-4
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water - 10 ml.

Research Overview

Ipamorelin is a synthetic pentapeptide investigated as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). In experimental systems it is used as a tool compound to study growth hormone secretion, pituitary responsiveness and ghrelin-pathway signaling without broad off-target receptor activation.

Primary Research Areas

  • Growth hormone (GH) secretion: models examining pulsatile GH release, pituitary sensitivity and GHS-R–mediated signaling.
  • Ghrelin / GHS-R pathways: research on selective ghrelin receptor agonism, downstream cascades and endocrine network interactions.
  • Endocrine & metabolic models: studies of hypothalamic–pituitary axes, energy-balance signaling and hormone-regulation frameworks.
  • Gastrointestinal motility research: experimental systems exploring ghrelin-related effects on GI motility and smooth-muscle activity.

CJC-1295 NO DAC 5mg

CJC-1295 NO DAC 5 mg research-grade lyophilized peptide powder supplied in a glass vial. CJC-1295 NO DAC, also known as Modified GRF (1-29) or Mod GRF 1-29, is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH) studied in experimental models of pituitary growth hormone release, GHRH receptor agonism and pulsatile GH secretion.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Form
Lyophilized peptide powder
Content
5 mg CJC-1295 NO DAC per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)
Molecular formula
C152H252N44O42
Molecular weight
~3367.9 g·mol⁻¹
Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
CAS number
863288-34-0
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water - 10 ml.

Research Overview

CJC-1295 NO DAC (Modified GRF 1-29) is a synthetic analog of Growth Hormone-Releasing Hormone composed of the first 29 amino acids of native GHRH with selected substitutions to enhance stability and receptor affinity. In experimental in vitro and in vivo models it is used to investigate pituitary growth hormone release, GHRH receptor activation and short-lived, pulsatile GH secretion patterns under controlled conditions.

Primary Research Areas

  • GHRH receptor agonism: used to study selective activation of the Growth Hormone-Releasing Hormone receptor and downstream cAMP/PKA signaling in pituitary and related cellular models.
  • Growth hormone (GH) release: applied in experimental systems evaluating GH pulse amplitude and frequency, pituitary responsiveness and feedback regulation of the somatotropic axis.
  • Pulsatile secretion patterns: investigated for its short half-life profile and use in models designed to mimic physiological, pulsatile GH release rather than continuous exposure paradigms.
  • Pituitary function assessment: included in research protocols probing pituitary reserve, GH–IGF-1 axis integrity and interactions with other hypothalamic–pituitary hormones in animals and ex vivo tissues.
  • Combination with GHRPs/GHSs: used in combination studies with growth hormone secretagogues (GHRPs/GHSs) to explore potential synergistic or additive effects on GH release and downstream signaling endpoints in laboratory models.
 
Powered by Phoca Cart